
Vivoryon Therapeutics
Biopharmaceutical company focused on the development of innovative small molecule drugs.
Market cap
$49.3m
Enterprise value
$39m
Share price
€1.61 VVY.AS
Authorizing premium user...
Biopharmaceutical company focused on the development of innovative small molecule drugs.